3 completed. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 1 | Completed 1 |
Follow Schizo Affective Disorder: new trials by email Literature Review of Schizo Affective Disorder trials Research Report on Schizo Affective Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic Disorders Intranasal Insulin - Psychosis, Schizophrenia | Phase 2 | Completed | Mclean Hospital | 87 | 2019-10-01 | 2026-09-03 |
| D-serine Augmentation of Neuroplasticity D-serine, Placebo - Schizophrenia, Schizo Affective Disorder | Phase 1 / Phase 2 | Completed | New York State Psychiatric Institute | 45 | 2019-03-13 | 2022-06-14 |
| Levetiracetam in Early Psychosis Levetiracetam, Placebo - Psychosis, Schizophrenia | Phase 2 | Completed | NYU Langone Health | 48 | 2017-08-18 | 2022-11-21 |
Psychotic Disorders (3) · Schizophrenia (3) · Insulin Resistance (1)
Mental Disorders (3) · Schizophrenia Spectrum and Other Psychotic Disorders (3) · Glucose Metabolism Disorders (1) · Hyperinsulinism (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1)
Insulin (1) · Levetiracetam (1)
Mclean Hospital (1) · NYU Langone Health (1) · New York State Psychiatric Institute (1)
United States (3)
Donald Goff, MD (1) · Virginie-Anne Chouinard, M.D. (1)